The diagnosis and subclassification of heart failure with preserved ejection fraction: a review
Authors:
Open Access
- 27 March 2026
- journal article
- review article
- Published by Springer Nature in Heart Failure Reviews
- Vol. 31 (1)
Abstract
The incidence and prevalence of Heart Failure with Preserved Ejection Fraction (HFpEF) continues to rise and has a mortality rate comparable to that of Heart Failure with Reduced Ejection Fraction (HFrEF). Whilst there is general agreement on the diagnostic criteria for HFrEF, the diagnostic criteria for HFpEF vary significantly which has resulted in inconsistent and varying inclusion criteria in clinical trials for this challenging syndrome. The HFpEF population is diverse and heterogeneous and various schemes of subcategorisation have been proposed. Failure of treatment trials to date can be explained, in part, by failure to consider the underlying sub-phenotypes within the HFpEF population. This review discusses the diagnostic uncertainty surrounding HFpEF and details the historical progression in the understanding of diastolic dysfunction and its role in the heart failure syndrome. An analysis of diagnostic criteria and suggested phenotypic subcategorisation is accompanied by a discussion of echocardiographic and invasive haemodynamic criteria. A detailed summary of the varied inclusion criteria and definitions employed in recent clinical trials is provided.Keywords
Funding Information
- Royal College of Surgeons in Ireland
This publication has 76 references indexed in Scilit:
- Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection FractionJAMA Cardiology, 2024
- Effect of Sacubitril/Valsartan vs Valsartan on Left Atrial Volume in Patients With Pre–Heart Failure With Preserved Ejection FractionJAMA Cardiology, 2023
- Effect of Personalized Accelerated Pacing on Quality of Life, Physical Activity, and Atrial Fibrillation in Patients With Preclinical and Overt Heart Failure With Preserved Ejection FractionJAMA Cardiology, 2023
- Predictive Value of H2FPEF Score in Patients with Heart Failure with Preserved Ejection FractionESC Heart Failure, 2021
- Effect of Praliciguat on Peak Rate of Oxygen Consumption in Patients With Heart Failure With Preserved Ejection FractionJAMA, 2020
- Effect of Neladenoson Bialanate on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection FractionJAMA, 2019
- Sex‐related differences in left ventricular diastolic function and arterial elastance during admission in patients with heart failure with preserved ejection fraction: The PURSUIT HFpEF studyClinical Cardiology, 2018
- Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection FractionJAMA, 2018
- Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection FractionJAMA, 2013
- Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection FractionJAMA, 2013